Loading clinical trials...
Loading clinical trials...
Stroke Risk Among Users of Typical vs. Atypical Antipsychotics Stratified by Broad Age Group, a Post-authorization Safety Study
Conditions
Interventions
Haloperidol
Typical Antipsychotics
+1 more
Locations
1
United States
Janssen Investigative Site
Titusville, New Jersey, United States
Start Date
May 6, 2019
Primary Completion Date
May 31, 2019
Completion Date
May 31, 2019
Last Updated
June 25, 2025
NCT06258538
NCT07371455
NCT05093673
NCT07253181
NCT06870812
NCT04119544
Lead Sponsor
Janssen Research & Development, LLC
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions